Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 130104-32-4
2. Lsl8e59v2v
3. 130104-32-4 (nitrate)
4. Ebernet
5. 1-(2,4-dichloro-10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-yl)-1h-imidazole Nitrate
6. 1h-imidazole, 1-(2,4-dichloro-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)-, Mononitrate
7. 1h-imidazole, 1-(2,4-dichloro-10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-yl)-, Nitrate (1:1)
8. 1-(4,6-dichloro-2-tricyclo(9.4.0.03,8)pentadeca-1(15),3(8),4,6,11,13-hexaenyl)imidazole;nitric Acid
9. 1-(4,6-dichloro-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenyl)imidazole;nitric Acid
10. 1h-imidazole, 1-(2,4-dichloro-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)-, Nitrate (1:1)
11. Ebernet (tn)
12. Unii-lsl8e59v2v
13. 1-(1,3-dichloro-6,11-dihydro-5h-dibenzo[1,2-a:1',4'-e][7]annulen-11-yl)imidazole,nitric Acid
14. Schembl1649316
15. Chembl4534605
16. Dtxsid80926597
17. Hy-106542a
18. Cs-0079200
19. D07884
20. B2692-048109
21. 1-(2,4-dichloro-10,11-dihydro-5h-dibenzo(a,d)(7)annulen-5-yl)-1h-imidazole Nitrate (1:1)
22. Nitric Acid--1-(2,4-dichloro-10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-yl)-1h-imidazole (1/1)
| Molecular Weight | 392.2 g/mol |
|---|---|
| Molecular Formula | C18H15Cl2N3O3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 391.0490467 g/mol |
| Monoisotopic Mass | 391.0490467 g/mol |
| Topological Polar Surface Area | 83.9 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 416 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Eberconazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eberconazole, including repackagers and relabelers. The FDA regulates Eberconazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eberconazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eberconazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eberconazole supplier is an individual or a company that provides Eberconazole active pharmaceutical ingredient (API) or Eberconazole finished formulations upon request. The Eberconazole suppliers may include Eberconazole API manufacturers, exporters, distributors and traders.
click here to find a list of Eberconazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Eberconazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eberconazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eberconazole GMP manufacturer or Eberconazole GMP API supplier for your needs.
A Eberconazole CoA (Certificate of Analysis) is a formal document that attests to Eberconazole's compliance with Eberconazole specifications and serves as a tool for batch-level quality control.
Eberconazole CoA mostly includes findings from lab analyses of a specific batch. For each Eberconazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eberconazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Eberconazole EP), Eberconazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eberconazole USP).
LOOKING FOR A SUPPLIER?
